SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Progress Note 1 — Satchel Paige

PatientSatchel Paige
Date of birth1953-07-07
IdentifiersMRN HR-ML047-SYN; SSN (made up) 000-47-3381
Document date2026-07-14
AuthorDelphine Whitaker-Osei, MD
CustodianSt. Posthumous Health Center

Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.

Subjective

The patient attends this visit for establishing primary care for two years of breathlessness on exertion and a morning cough: history, examination, blood tests including alpha-1 antitrypsin and eosinophils, ECG, NT-proBNP, cardiovascular risk, vaccines, a reliever inhaler and a pulmonology consultation. [S]

Objective

Hemoglobin: 15.2 g/dL; White blood cells: 7.1 10*3/uL; Eosinophils (absolute): 0.08 10*3/uL; Alpha-1 antitrypsin: 142 mg/dL; Sodium: 140 mmol/L; Potassium: 4.3 mmol/L; Creatinine: 1.08 mg/dL; eGFR (CKD-EPI 2021, race-free): 71 mL/min/1.73 m²; Glucose: 96 mg/dL; HbA1c: 5.6%; ALT: 21 U/L; Total cholesterol: 224 mg/dL (high); HDL cholesterol: 44 mg/dL; LDL cholesterol (calculated): 148 mg/dL (high); Triglycerides: 160 mg/dL (high); NT-proBNP: 92 pg/mL; PHQ-9: 5; AUDIT-C: 1. [S]

Vital Signs

DateMeasureValueUnitProvenance
2026-07-14Body height191cmS
2026-07-14Body weight82.6kgS
2026-07-14Body mass index (BMI) [Ratio]22.6kg/m2S
2026-07-14Systolic blood pressure136mm[Hg]S
2026-07-14Diastolic blood pressure82mm[Hg]S
2026-07-14Heart rate84/minS
2026-07-14Respiratory rate18/minS
2026-07-14Body temperature36.7CelS
2026-07-14Oxygen saturation in Arterial blood by Pulse oximetry94%S

Results

DateMeasureValueUnitReference rangeFlagProvenance
2026-07-14Hemoglobin [Mass/volume] in Blood15.2g/dL13.2-17.1 g/dLNormalS
2026-07-14Leukocytes [#/volume] in Blood by Automated count7.110*3/uL3.8-10.8 10*3/uLNormalS
2026-07-14Eosinophils [#/volume] in Blood by Automated count0.0810*3/uLFor COPD treatment decisions: below 0.10 argues against an inhaled corticosteroid; 0.30 or more favors oneNormalS
2026-07-14Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma142mg/dL90-200 mg/dLNormalS
2026-07-14Sodium [Moles/volume] in Serum or Plasma140mmol/L135-146 mmol/LNormalS
2026-07-14Potassium [Moles/volume] in Serum or Plasma4.3mmol/L3.5-5.3 mmol/LNormalS
2026-07-14Creatinine [Mass/volume] in Serum or Plasma1.08mg/dL0.7-1.3 mg/dLNormalS
2026-07-14Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M71mL/min/{1.73_m2}>=60 mL/min/1.73 m²NormalS
2026-07-14Glucose [Mass/volume] in Serum or Plasma96mg/dL65-99 mg/dLNormalS
2026-07-14Hemoglobin A1c/Hemoglobin.total in Blood5.6%<=5.6%NormalS
2026-07-14Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma21U/L9-46 U/LNormalS
2026-07-14Cholesterol [Mass/volume] in Serum or Plasma224mg/dL<=199 mg/dLHighS
2026-07-14Cholesterol in HDL [Mass/volume] in Serum or Plasma44mg/dL>=40 mg/dLNormalS
2026-07-14Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation148mg/dL<=99 mg/dLHighS
2026-07-14Triglyceride [Mass/volume] in Serum or Plasma160mg/dL<=149 mg/dLHighS
2026-07-14Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma92pg/mLBelow 125 pg/mL makes heart failure unlikely in an outpatientNormalS
2026-07-14Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]5{score}S
2026-07-14Total score [AUDIT-C]1{score}S

Medications

MedicationFrequencyRouteDatesStatusEvidence
Albuterol 90 micrograms per inhalation metered-dose inhaler with a spacer, two inhalations every four hours as needed for breathlessnessTwo inhalations with a spacer every 4 hours as neededRespiratory tract route2026-07-14activeS
Atorvastatin 20 mg tablet once a dayOne tablet each eveningOral route2026-07-14activeS

Allergies and Intolerances

AllergyReactionStatusEvidence
No known allergyactiveS

Problems

ProblemClinical statusVerificationCodeProvenance
Breathlessness on exertion for about two years, now after one flight of stairs or a block on the level (mMRC 2), with a morning cough and a little clear sputum most days; no chest pain, ankle swelling, orthopnea, wheeze at rest or weight loss; a former smoker of about 30 pack-years; cause under evaluation with spirometry and a pulmonology consultationactiveconfirmed R06.09S — Synthetic presenting problem anchored to his documented emphysema; superseded when spirometry at the consultation confirmed COPD.
Former cigarette smoker, about 30 pack-years, stopped eleven years ago on his own; no use sinceactiveconfirmed Z87.891S — Synthetic smoking history: whether he smoked is not documented in the sources read, so the history is synthetic and labeled as such.
Hyperlipidemia: LDL 148 mg/dL, HDL 44 and triglycerides 160 at intake; estimated 10-year cardiovascular risk about 18 percent; atorvastatin started by shared decisionactiveconfirmed E78.5S — Synthetic cardiovascular risk factor anchored to his documented heart trouble; not a claim about his real lipids.

Assessment

Plan of Treatment